Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001808805-22-000012
Filing Date
2022-02-24
Accepted
2022-02-24 17:16:03
Documents
5
Effectiveness Date
2022-02-24

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82022evergreen.htm S-8 76887
2 EX-FILING FEES exhibit107filingfeetables2.htm EX-FILING FEES 19696
3 EX-5.1 exhibit51wsgrlegalopinion2.htm EX-5.1 9687
4 EX-23.1 exhibit231consent-sx8feb20.htm EX-23.1 2509
5 image_1a.jpg GRAPHIC 74541
  Complete submission text file 0001808805-22-000012.txt   212508
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262992 | Film No.: 22672617
SIC: 3826 Laboratory Analytical Instruments